Related Experiment Videos
Efficacy and safety of ibuprofen for hemophilic arthropathy
Abstract:
The safety and usefulness of ibuprofen (Motrin) were evaluated in 15 patients suffering from hemophilic arthropathy via a double-blind protocol with individual crossover. No significant increase in hemorrhagic episodes or alteration in platelet function was observed. A decrease in morning stiffness was noted in nine patients, and three decreased markedly their use of other pain medications. We conclude that ibuprofen represents a relatively safe agent for the management of discomfort caused by hemophilic arthropathy in a select group of hemophilic patients.
Insights
Ibuprofen (Motrin) was found to be relatively safe for managing hemophilic arthropathy pain. This study showed no increase in bleeding episodes, with some patients experiencing reduced stiffness and medication use.
Area of Science:
- Rheumatology
- Hematology
- Pharmacology
Background:
- Hemophilic arthropathy causes significant discomfort and joint damage.
- Limited safe pain management options exist for hemophilic patients.
Purpose of the Study:
- To evaluate the safety and efficacy of ibuprofen (Motrin) in patients with hemophilic arthropathy.
- To assess the impact of ibuprofen on hemorrhagic episodes and platelet function.
Main Methods:
- A double-blind, individual crossover study.
- 15 patients with hemophilic arthropathy participated.
- Evaluated safety, bleeding episodes, platelet function, pain, and medication use.
Main Results:
- No significant increase in hemorrhagic episodes was observed.
- Platelet function remained unaltered.
- Nine patients reported decreased morning stiffness, and three reduced their use of other pain relievers.
Conclusions:
- Ibuprofen appears to be a relatively safe option for pain management in select hemophilic arthropathy patients.
- Further research may explore long-term effects and broader applications.